APP and early-onset autosomal dominant Alzheimer disease: Long-term sitagliptin treatment attenuated memory impairment and reduced inflammation, nitrosative stress, and amyloid-β protein and amyloid precursor protein accumulation in the brains of transgenic mice with Alzheimer’s disease [18].